Description

This issue of Vital Signs, released on April 14, 2008, provides an strategic overview of current molecular diagnostic tests and a discussion of future needs. Additionally, a company spotlight is provided for Nanosphere, an emerging nanotechnology based molecular diagnostics company. Reimbursement and regulatory news from the FDA is also provided for the week of March 31 - April 4, 2008.